Tags : P-ll/lll Study

Inovio Reports FDA’s Partial Clinical Hold on P-II/III Trial of

Shots: The US FDA has put a partial clinical hold on P-II/III study of Inovio’s INO-4800, including its CELLECTRA 2000 delivery device to be used in the trial because it has additional questions about the trial Inovio is actively working to address the FDA’s questions and plans to respond in Oct’2020 after which the FDA […]Read More